• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS CARDIOBLATE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS CARDIOBLATE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING Back to Search Results
Model Number 49341
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stroke/CVA (1770)
Event Date 08/25/2022
Event Type  Injury  
Manufacturer Narrative
¿this report is being submitted as part of a retrospective review and remediation for capa 564121 per (b)(4).¿ medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The patient had a concomitant surgical procedure of mitral valve repair through a minimally invasive thoracotomy.During the same procedure on (b)(6) 2022) a cryoflex probe powered by a cryo-console, and a cardioblate lp clamp powered by a valley lab ft-10 generator were used.The left atrial appendage was successfully sutured closed.Left pulmonary vein (lpv) conduction block was not performed (d/t minimally invasive port access approach) and right pulmonary vein (rpv) conduction block was successfully achieved.Approximately 15 days post procedure (b)(6) 2022) the patient experienced acute infarct of right parietooccipital.Patient c/o dizziness and ear fullness x4 days.Sent to hospital by pcp for head ct, in which results indicated acute infarct of right parieto-occipital lobe.Inr therapeutic.The adverse event was deemed by the site as not related to the study devices or study procedure, but possibly related to the concomitant procedure.The adverse event was deemed by the sponsor not related to the study devices, but related to the study procedure and concomitant procedure.The adverse event was deemed by the cec as possible related to the cryoflex probe, cardioblate clamp, study procedure and concomitant procedure but not related to the cryo-console.Comments from cec: stated that a non disabling ischemic stroke was confirmed on mri and the devices could have caused a blood clot if the anticoagulation was not appropriately done.Medtronic received additional information that the adverse event was deemed by the site as possibly related to the study procedure and study devices.The site provided the following rationale for relating the adverse event to the devices: cerebrovascular accident is a known potential risk of the devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOBLATE
Type of Device
SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer (Section G)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18684558
MDR Text Key335113531
Report Number2184009-2024-00076
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182610
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/30/2022
Device Model Number49341
Device Catalogue Number49341
Device Lot Number836C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/26/2022
Initial Date FDA Received02/12/2024
Date Device Manufactured10/30/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age59 YR
Patient SexMale
Patient Weight95 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-